JP2006517795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006517795A5 JP2006517795A5 JP2006501879A JP2006501879A JP2006517795A5 JP 2006517795 A5 JP2006517795 A5 JP 2006517795A5 JP 2006501879 A JP2006501879 A JP 2006501879A JP 2006501879 A JP2006501879 A JP 2006501879A JP 2006517795 A5 JP2006517795 A5 JP 2006517795A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44823103P | 2003-02-18 | 2003-02-18 | |
| US60/448,231 | 2003-02-18 | ||
| PCT/EP2004/001554 WO2004074493A1 (en) | 2003-02-18 | 2004-02-18 | Recombinant mva and method for generation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010255796A Division JP5166505B2 (ja) | 2003-02-18 | 2010-11-16 | 組換えｍｖａおよびその生産方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006517795A JP2006517795A (ja) | 2006-08-03 |
| JP2006517795A5 true JP2006517795A5 (enExample) | 2006-10-26 |
| JP4686443B2 JP4686443B2 (ja) | 2011-05-25 |
Family
ID=32908561
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501879A Expired - Fee Related JP4686443B2 (ja) | 2003-02-18 | 2004-02-18 | 組換えｍｖａおよびその生産方法 |
| JP2010255796A Expired - Fee Related JP5166505B2 (ja) | 2003-02-18 | 2010-11-16 | 組換えｍｖａおよびその生産方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010255796A Expired - Fee Related JP5166505B2 (ja) | 2003-02-18 | 2010-11-16 | 組換えｍｖａおよびその生産方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060002896A1 (enExample) |
| EP (1) | EP1594970B1 (enExample) |
| JP (2) | JP4686443B2 (enExample) |
| CN (1) | CN1723285B (enExample) |
| AT (1) | ATE403005T1 (enExample) |
| DE (1) | DE602004015418D1 (enExample) |
| DK (1) | DK1594970T3 (enExample) |
| WO (1) | WO2004074493A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10143490C2 (de) * | 2001-09-05 | 2003-12-11 | Gsf Forschungszentrum Umwelt | Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen |
| AU2003297499A1 (en) | 2002-12-23 | 2004-07-22 | City Of Hope | Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| EP2199400A1 (en) | 2008-12-22 | 2010-06-23 | Emergent Product Development Germany GmbH | Single recombination system and methods of use |
| CN102559611B (zh) * | 2011-06-23 | 2015-04-22 | 江苏省农业科学院 | 一种无筛选标记的双表达重组mva病毒及其构建方法 |
| US10736962B2 (en) * | 2016-02-25 | 2020-08-11 | Memorial Sloan Kettering Cancer Center | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors |
| NZ750578A (en) * | 2016-08-19 | 2023-05-26 | Sementis Ltd | Viral vaccines |
| WO2021260065A1 (en) | 2020-06-24 | 2021-12-30 | Consejo Superior De Investigaciones Científicas (Csic) | Mva-based vaccine against covid-19 expressing sars-cov-2 antigens |
| EP3928789A1 (en) | 2020-06-24 | 2021-12-29 | Consejo Superior de Investigaciones Científicas (CSIC) | Mva-based vaccine against covid-19 expressing sars-cov-2 antigens |
| WO2022269003A1 (en) | 2021-06-23 | 2022-12-29 | Consejo Superior De Investigaciones Cientificas | MVA-BASED VACCINE EXPRESSING A PREFUSION-STABILIZED SARS-CoV-2 S PROTEIN |
| EP4108257A1 (en) | 2021-06-23 | 2022-12-28 | Consejo Superior De Investigaciones Científicas | Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein |
| EP4316514A1 (en) | 2022-08-03 | 2024-02-07 | Consejo Superior de Investigaciones Científicas (CSIC) | Mva-based vectors and their use as vaccine against sars-cov-2 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015672A1 (en) * | 1991-03-07 | 1992-09-17 | Virogenetics Corporation | Genetically engineered vaccine strain |
| UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| EP1012276A2 (en) * | 1997-02-24 | 2000-06-28 | Therion Biologics Corporation | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
| BR0111366A (pt) * | 2000-05-24 | 2003-05-20 | Merial Sas | Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv) |
| GB0111442D0 (en) * | 2001-05-10 | 2001-07-04 | Isis Innovation | Method for preparing recombinant virus |
-
2004
- 2004-02-18 DE DE200460015418 patent/DE602004015418D1/de not_active Expired - Lifetime
- 2004-02-18 CN CN2004800018495A patent/CN1723285B/zh not_active Expired - Fee Related
- 2004-02-18 AT AT04712013T patent/ATE403005T1/de active
- 2004-02-18 EP EP20040712013 patent/EP1594970B1/en not_active Expired - Lifetime
- 2004-02-18 WO PCT/EP2004/001554 patent/WO2004074493A1/en not_active Ceased
- 2004-02-18 JP JP2006501879A patent/JP4686443B2/ja not_active Expired - Fee Related
- 2004-02-18 DK DK04712013T patent/DK1594970T3/da active
-
2005
- 2005-06-10 US US11/149,793 patent/US20060002896A1/en not_active Abandoned
-
2010
- 2010-11-16 JP JP2010255796A patent/JP5166505B2/ja not_active Expired - Fee Related